Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes-Reference-Cited by-同舟云学术

Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes

Published:1993-10 Issue:2 Volume:70 Page:103-107
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Chen Zhong,Morgan Rodman,Berger Carol S.,Pearce-Birge Lori,Stone John F.,Sandberg Avery A.

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference25 articles.

1. The Chromosomes in Human Cancer and Leukemia;Sandberg,1991

2. The Chromosomes in Human Cancer and Leukemia;Sandberg,1991

3. The Chromosomes in Human Cancer and Leukemia;Sandberg,1991

4. The Chromosomes in Human Cancer and Leukemia;Sandberg,1991

5. Utility of molecular genetic analysis of bcr rearrangement in the diagnosis of chronic myeloid leukemia;Benn;Cancer Genet Cytogenet,1987

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome–Positive Acute Myeloid Leukemia in Adults;Biology of Blood and Marrow Transplantation;2018-08

2. Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis;International Journal of Hematology;2015-12-12

3. Geographic/ethnic variability of chromosomal and molecular abnormalities in leukemia;Expert Review of Anticancer Therapy;2015-07-27

4. Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis;Leukemia;2013-04-12

5. Deletions of the 3′ BCR and 5′ ABL regions in patients with Philadelphia-positive chronic myeloid leukemia: a one-step process occurring in about 10% of the cases without any evidence of genetic instability in the target cells;Cancer Genetics and Cytogenetics;2005-07